HopeStage
Back to all studies
TerminatedNCT01454453

Optimisation of Antipsychotic Drug Use in Older People

Medication studyAges 60–95United KingdomSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 60 years to 95 years.

Listed locations
LondonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateMay 2012
Recruitment status
Terminated
Enrollment listed in the registry
64
Sponsor
Institute of Psychiatry, London
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United Kingdom
Age range
From 60 Years to 95 Years
Official registry ID
NCT01454453
Official title
Show the full official title

Rationalisation of Antipsychotic Drug Use in Older People, Using [18F]-Fallypride PET

Recruitment & locations

Terminated

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Institute of Psychiatry, London, a research institute.

Does this study involve medication?

Yes. The study involves medication, including Patients- dose titration.

Who can participate?

Listed age limits: 60 years to 95 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies